“…The most obvious explanation that reduced CMAP predicts weakness, which by itself contributes to 1-year mortality, was invalidated as the association between reduced CMAP and 1-year mortality was independent of weakness. This suggests that CMAP reduction and weakness possibly identify different, though overlapping, phenotypes of neuromuscular involvement, as recently hypothesized [14]. Alternatively, this could point to subclinical weakness not captured by the MRC sum-score.…”